- Home
- KMDA vs UPXI Comparison
KMDA vs UPXI Comparison
Compare KMDA & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- UPXI
- Stock Information
- Founded
- KMDA 1990
- UPXI 2018
- Country
- KMDA Israel
- UPXI United States
- Employees
- KMDA N/A
- UPXI N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- KMDA Health Care
- UPXI Health Care
- Exchange
- KMDA Nasdaq
- UPXI Nasdaq
- Market Cap
- KMDA 410.6M
- UPXI 481.8M
- IPO Year
- KMDA N/A
- UPXI 2021
- Fundamental
- Price
- KMDA $6.95
- UPXI $6.75
- Analyst Decision
- KMDA Strong Buy
- UPXI
- Analyst Count
- KMDA 2
- UPXI 0
- Target Price
- KMDA $13.00
- UPXI N/A
- AVG Volume (30 Days)
- KMDA 50.0K
- UPXI 6.0M
- Earning Date
- KMDA 11-12-2025
- UPXI 05-16-2025
- Dividend Yield
- KMDA 2.90%
- UPXI N/A
- EPS Growth
- KMDA 27.97
- UPXI N/A
- EPS
- KMDA 0.32
- UPXI N/A
- Revenue
- KMDA $169,517,000.00
- UPXI $16,562,327.00
- Revenue This Year
- KMDA $14.49
- UPXI N/A
- Revenue Next Year
- KMDA $10.12
- UPXI $147.95
- P/E Ratio
- KMDA $20.92
- UPXI N/A
- Revenue Growth
- KMDA 9.67
- UPXI 1378.83
- 52 Week Low
- KMDA $5.17
- UPXI $1.90
- 52 Week High
- KMDA $9.16
- UPXI $22.57
- Technical
- Relative Strength Index (RSI)
- KMDA 44.35
- UPXI 52.73
- Support Level
- KMDA $6.84
- UPXI $5.77
- Resistance Level
- KMDA $7.15
- UPXI $6.84
- Average True Range (ATR)
- KMDA 0.19
- UPXI 0.62
- MACD
- KMDA -0.00
- UPXI -0.03
- Stochastic Oscillator
- KMDA 23.02
- UPXI 56.79
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.